Clinical Trials Logo

Clinical Trial Summary

Paracetamol,a classical analgesic agent,constitutes an essential component of multi-modal analgesia. This medication is generally safe, well tolerated and effective within recommended daily dose.The purpose of the study is to evaluate the efficacy and safety of Paracetamol Injection as adjuvant to morphine-based post-operative analgesia, as well as to explore the reasonable dosage of paracetamol among Chinese population under above-mentioned circumstance.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02811991
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact
Status Completed
Phase Phase 2/Phase 3
Start date June 2016
Completion date May 2019

See also
  Status Clinical Trial Phase
Withdrawn NCT03603626 - Preemptive Pregabalin in Myringoplasty N/A
Terminated NCT03618823 - Non-opioids for Analgesia After Adenotonsillectomy in Children Phase 1/Phase 2
Completed NCT02851394 - Advantage of Tramadol in Local Analgesia Post-Sternotomy Phase 4
Completed NCT02782767 - Comparison of Continuous Wound Catheter Infusion Versus Continuous Epidural Infusion in Abdominal Surgery N/A
Completed NCT03965156 - Bilateral Ultrasound Guided ESP Block Versus TAP Block on Post-operative Analgesia After Total Abdominal Hysterectomy N/A
Recruiting NCT06021327 - Comparison Between Erector Spinae Plane Block And Retrolaminar Block In Patients Undergoing VATS. N/A
Completed NCT05288738 - Comparing Post-Operative Analgesic Effects of PCAM With Dexmedetomidine 1 mcg/ml vs PCAM With Dexmedetomidine 2 mcg/ml Phase 4
Terminated NCT01625780 - Comparing Ilioinguinal Single-shot and Three-layer Blocks N/A
Terminated NCT04791761 - Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy Phase 1/Phase 2